The immune system

Physiological Basis of Aging and Geriatrics, Fourth Edition

Volumn , Issue , 2007, Pages 231-248

  Ginaldi, Lia ^a   Sternberg, Hal ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b BIOTIME INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055226738     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (115)

1. Cerottini JC, MacDonald HR. The cellular basis of T-cell memory. Annu Rev Immunol 1989; 7: 77-89.
2. Bachmann MF, Wolint P, Schwarz K, et al. Functional properties and lineage relationship of CD8+ T-cell subsets identified by expression of IL-7 receptor alpha and CD62L. J Immunol 2005; 175(7): 4686-4696.
3. Takata H, Takiguchi M. Three memory subsets of human CD8+ T-cells differently expressing three cytolytic effector molecules. J Immunol 2006; 177(7): 4330-4340.
4. Taams LS, Akbar AN. Peripheral generation and function of CD4+CD25+ regulatory T cells. Curr Top Microbiol Immunol 2005; 293: 115-131.
5. Maggi E, Cosmi L, Liotta F, et al. Thymic regulatory T cells. Autoimmun Rev 2005; 4(8): 579-586.
6. Jiang S, Lechler RI, He XS, et al. Regulatory T cells and transplantation tolerance. Hum Immunol 2006; 67(10): 765-776.
7. Liu H, Leung BP. CD4+CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol 2006; 33(5-6): 519-524.
8. Zhang C, Zhang J, Tian Z. The regulatory effect of natural killer cells: do “NK-reg cells” exist? Cell Mol Immunol 2006; 3(4): 241-254.
9. Grabstein KH, Maliszewski CR, Shanebeck K, et al. The regulation of T-cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J Immunol 1993; 150(8 Pt 1): 3141-3147.
10. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999; 108(1): 1-7.
11. Kabelitz D, Wesch D, Oberg HH. Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit Rev Immunol 2006; 26(4): 291-306.
12. Moretta L, Ferlazzo G, Bottino C, et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006; 214(1): 219-228.
13. Shearer GM. Th1/Th2 changes in aging. Mech Ageing Dev 1997; 94(1-3): 1-5.
14. Cossarizza A, Ortolani C, Monti D, et al. Cytometric analysis of immunosenescence. Cytometry 1997; 27(4): 297-313.
15. Papasteriades C, Boki K, Pappa H, et al. HLA phenotypes in healthy aged subjects. Gerontology 1997; 43(3): 176-181.
16. Wick G, Jansen-Durr P, Berger P, et al. Diseases of aging. Vaccine 2000; 18(16): 1567-1583.
17. Bender BS, Nagel JE, Adler WH, et al. Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. J Am Geriatr Soc 1986; 34(9): 649-654.
18. Pawelec G. Immunity and ageing in man. Exp Gerontol 2006; 41(12): 1239-1242.
19. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine 2000; 18(16): 1613-1620.
20. Franceschi C, Monti D, Sansoni P, et al. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995; 16(11): 549-550.
21. Khanna KV, Markham RB. A perspective on cellular immunity in the elderly. Clin Infect Dis 1999; 28(4): 710-735.
22. Ligthart GJ, Corberand JX, Geertzen HG, et al. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev 1990; 55(1): 89-105.
23. Pamer EG. Antigen presentation in the immune response to infectious diseases. Clin Infect Dis 1999; 28(4): 714-716.
24. Franceschi C, Valensin S, Fagnoni F, et al. Biomarkers of immunosenescence: the challenge of heterogeneity and the role of antigenic load. Exp Gerontol 1999; 34(8): 911-921.
25. De Martinis M, Franceschi C, Monti D, et al. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005; 579(10): 2035-2039.
26. Ginaldi L, De Martinis M, D’Ostilio A, et al. Immunological changes in the elderly. Aging Clin Exp Res 1999; 11(5): 281-286.
27. Ginaldi L, De Martinis M, D’Ostilio A, et al. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: a quantitative flow cytometric analysis. Am J Hematol 2001; 67(2): 63-72.
28. Ginaldi L, Matutes E, Farahat U, et al. Differential expression of CD3 and CD7 in T-cell malignancies. A quantitative study by flow cytometry. Br J Haematol 1996; 93(4): 921-927.
29. Ginaldi L, De Martinis M, Matutes E, et al. Levels of expression of CD19 and CD20 in chronic B-lineage leukaemias. J Clin Pathol 1998; 51(5): 364-369.
30. De Martinis M, Modesti M, Loreto MF, et al. Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci 2000; 68(2): 139-151.
31. Ginaldi L, De Martinis M, Modesti M, et al. Immunophenotypical changes of T-lymphocytes in the elderly. Gerontology 2000; 46(5): 242-248.
32. Ginaldi L, De Martinis M, D’Ostilio A, et al. The immune system in the elderly. III. Innate immunity. Immunol Res 1999; 20(2): 117-126.
33. Mountz JD, Wu J, Jzhou T, et al. Cell death and longevity: implications of Fas-mediated apoptosis in T-cell senescence. Immunol Rev 1997; 160: 19-30.
34. Linton PJ, Haynes L, Tsui L, et al. From naïve to effector- alterations with aging. Immunol Rev 1997; 160: 9-18.
35. Zanni F, Vescovini R, Biasini C, et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 2003; 38(9): 981-987.
36. Alberti S, Cevenini E, Ostan R, et al. Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ Tcells in humans. Mech Ageing Dev 2006; 127(6): 560-566.
37. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908: 244-254.
38. Licastro F, Candore G, Lio D, et al. Innate immunita and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005; 2: 8-27.
39. Mooradian AD, Reed RL, Osterweil D, et al. Detectable serum levels of tumor necrosis factor alpha may predict early mortality in elderly institutionalized patients. Am Geriatr Soc 1991; 39(9): 891-894.
40. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community- dwelling men and women: the Framingham Heart Study. Am J Med 2003; 115(6): 429-435.
41. Cappola AR, Xue QL, Ferrucci L, et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003; 88(5): 2019-2025.
42. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18(16): 1717-1720.
43. Ginaldi L, Di Benedetto MC, De Martinis M. Osteoporosis, inflammation and ageing. Immun Ageing 2005; 4: 2,14.
44. De Martinis M, Di Benedetto MC, Mengoli LP, et al. Senile osteoporosis: is it an immune-mediated disease? Inflamm Res 2006; 55(10): 399-404.
45. De Martinis M, Franceschi C, Monti D, et al. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80(3): 219-227.
46. Mullenix PS, Andersen CA, Starnes BW. Atherosclerosis as Inflammation. Ann Vasc Surg 2005; 19(1): 130-138.
47. Tiong AY, Brieger D. Inflammation and Coronary heart disease. Am Heart J 2005; 150(1): 11-18.
48. Venugopal SK, Devaraj S, Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells (potential for paracrine/autocrine effects). Am J Pathol 2005; 166(4): 1265-1271.
49. Stephan RP, Sanders VM, Witte PL. Stage specific alterations in murine B-lymphopoiesis with age. Int Immunol 1996; 8(4): 509-518.
50. Klinman NR, Kline GH. The B-cell biology of aging. Immunol Rev 1997; 160: 103-114.
51. Solana R, Pawelec G. Molecular and cellular basis of immunosenescence. Mech Ageing Dev 1998; 102(2-3): 115-129.
52. Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell Immunol 2005; 233(2): 102-108.
53. Johnson SA, Cambier JC. Senescence of the B Cell Compartment: implication for humoral immunity. Arthritis Res Ther 2004; 6(4): 131-139.
54. Song H, Price PW, Cerny J. Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev 1997; 160: 55-62.
55. Ginaldi L, De Martinis M, D’Ostilio A, et al. The immune system in the elderly. I. Specific humoral immunity. Immunol Res 1999; 20(2): 109-115.
56. Herrera E, Martinez AC, Blasco MA. Impaired germinal center reaction in mice with short telomeres. EMBO J 2000; 19(3): 472-481.
57. Akbar AN, Fletcher JM. Memory T-cell homeostasis and senescence during aging. 2005; 17(5): 480-485.
58. Ginaldi L, De Martinis M, D’Ostilio A, et al. The immune system in the elderly. II. Specific cellular immunity. Immunol Res 1999; 20(2): 109-115.
59. Pawelec G, Adibzadeh M, Solana R, et al. The T-cell in the ageing individual. Mech Ageing Dev 1997; 93(1-3): 35-45.
60. Fagnoni FF, Vescovini R, Passeri G, et al. Shortage of circulating naïve CD8+ T cells provides new insights on immunodeficiency in aging. Blood 2000; 95(9): 2860-2868.
61. Schwab R, Skabo P, Manavalan JS, et al. Expanded CD4+ and CD8+ T-cell clones in elderly humans. J Immunol 1997; 158(9): 4493-4499.
62. Fernandez-Gutierrez B, Jover JAA, De Miguel S, et al. Early lymphocyte activation in elderly humans: impaired T and T-dependent B-cell responses. Exp Gerontol 1999; 34(2): 217-229.
63. Swain S, Clise-Dwyer K, Haynes L. Homeostasis and the ageassociated defect of CD4 T cells. Semin Immunol 2005; 17(5): 370-377.
64. Linton PJ, Haynes L, Klinman NR, et al. Antigen-independent changes in naïve CD4 T cells with aging. J Exp Med 1996; 184(5): 1891-1900.
65. Fulop T, Larbi A, Wikby A, et al. Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 2005; 22(7): 589-603.
66. Tsakanaridis L, Spencer L, Culbertson N, et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003; 74(2): 296-308.
67. Coutinho A, Caramalho I, Seixas E, et al. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Curr Top Microbiol Immunol 2005; 293: 43-71.
68. Pawelec G, Wagner V, Adibzadeh M, et al. T-cell immunosenescence in vitro and in vivo. Exp Gerontol 1999; 34(3): 419-429.
69. Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev 2005; 204: 55-73.
70. Timm JA, Thoman ML. Maturation of CD4+ lymphocytes in the aged microenvironment results in a memory-enriched population. J Immunol 1999; 162(2): 711-717.
71. Goronzy JJ, Weyand CM. T-cell development and receptor diversity during aging. Curr Opin Immunol 2005; 17(5): 468-475.
72. Effros RB. Costimulatory mechanisms in the elderly. Vaccine 2000; 18(16): 1661-1665.
73. Pawelec G, Muller P, Rehbein A, et al. Extrathymic T-cell differentiation in vitro from human CD34+ stem cells. J Leukoc Biol 1998; 64(6): 733-739.
74. Douek DC, Koup RA. Evidence for thymic function in the elderly. Vaccine 2000; 18(16): 1638-1641.
75. McFarland R, Dowek DC, Koud RA, et al. Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci 2000; 97(8): 4215-4220.
76. Effros RB. Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. Am J Hum Gen 1998; 62(5): 1003-1007.
77. Ouyang Q, Wagner WM, Wikby A, et al. Large numbers of dysfunctional CD8+ T-lymphocytes bearing receptors for a single dominant CMVepitope in the very old. J Clin Immunol 2003; 23(4): 247-257.
78. Koch GR, Smith CM, Clark FJ, et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol 2005; 140(3): 540-546.
79. Ginaldi L, De Martinis M, D’Ostilio A, et al. Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry. Am J Clin Pathol 1997; 108(5): 585-592.
80. Ginaldi L, De Martinis M, D’Ostilio A, et al. Changes in antigen expressions on B-lymphocytes during HIV infection. Pathobiology 1998; 66(1): 17-23.
81. Bestilny LJ, Gill MJ, Mody CH, et al. Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 2000; 14(7): 771-780.
82. Castle SC. Clinical relevance of age related immune dysfunction. Clin Infect Dis 2000; 31(2): 578-585.
83. Mbawuike IN, Acuna CL, Walz KC, et al. Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12. Mech Ageing Dev 1997; 94(1-3): 25-39.
84. Krishnaraj R. Senescence and cytokines modulate the NK cell expression. Mech Ageing Dev 1997; 96(1-3): 89-101.
85. Wikby A, Johansson B, Ferguson F, et al. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol 1994; 29(5): 531-541.
86. Borrego F, Alonso ML, Galiani MD, et al. NK phenotypic markers and IL-2 response in NK cells from elderly people. Exp Gerontol 1999; 34(2): 253-265.
87. Rukavina D, Laskarin G, Rubesa G, et al. Age-related decline of perforin expression in human cytotoxic T-lymphocytes and natural killer cells. Blood 1998; 92(7): 2410-2420.
88. Trzonkowski P, Szmit E, Mysliwska J, et al. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 2004; 112(3): 258-267.
89. Trzonkowski P, Szmit E, Mysliwska J, et al. CD4+ CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol 2006; 119(3): 307-316.
90. Bruunsgaard H, Pedersen AN, Schroll M, et al. Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol 1999; 118(2): 235-241.
91. De Martinis M, Modesti M, Ginaldi L. Phenotypic and functional changes of circulating monocytes and polymorphonuclear leucocytes from elderly persons. Immunol Cell Biol 2004; 82(4): 415-420.
92. Esparza B, Sanchez H, Ruiz M, et al. Neutrophil function in elderly persons assessed by flow cytometry. Immunol Invest 1996; 25(3): 185-190.
93. Noble JM, Ford GA, Thomas TH. Effect of aging on CD11b and CD69 surface expression by vesicular insertion in human polymorphonuclear leucocytes. Clin Sci 1999; 97(3): 323-329.
94. Rhoades ER, Orme IM. Similar responses by macrophages from young and old mice infected with mycobacterium tuberculosis. Mech Ageing Dev 1998; 106(1-2): 145-153.
95. Sadeghi HM, Schnelle JF, Thoma JK, et al. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol 1999; 34(8): 959-970.
96. Ramos-Casals M, Brito-Zeron P, Lopez-Soto A, et al. Systemic autoimmune diseases in elderly patients: atypical presentation and association with neoplasia. Autoimmun Rev 2004; 3(5): 376-382.
97. Stacy S, Krolick KA, Infante AJ, et al. Immunological memory and late onset autoimmunity. Mech Ageing Dev 2002; 123(8): 975-985.
98. Weyand CM, Fulbright JW, Goronzy JJ. Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol 2003; 38(8): 833-841.
99. Stassen M, Fondel S, Bopp T, et al. Human CD25+ regulatory Tcells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004; 34(5): 1303-1311.
100. Ginaldi L, De Martinis M, D’Ostilio A, et al. Cell proliferation and apoptosis in the immune system in the elderly. Immunol Res 2000; 21(1): 31-38.
101. Phelouzat MA, Arbogast A, Laforge T, et al. Excessive apoptosis of mature T-lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev 1996; 88(1-2): 25-38.
102. Herndon FJ, Hsu HC, Mountz JD. Increased apoptosis of CD45RO- T cells with aging. Mech Ageing Dev 1997; 94(1-3): 123-134.
103. Weng NP, Palmer LD, Levine BL, et al. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation and aging. Immunol Rev 1997; 160: 43-54.
104. McConnell KR, Dynan WS, Hardin JA. The DNA-dependent protein kinase (p460) is cleaved during Fas-mediated apoptosis in Jurkat cells. J Immunol 1997; 158(5): 2083-2089.
105. Ginaldi L, De Martinis M, Monti D, et al. The immune system in the elderly: activation-induced and damage-induced apoptosis. Immunol Res 2004; 30(1): 81-94.
106. Ginaldi L, De Martinis M, Monti D, et al. Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol 2005; 26(2): 79-84.
107. Gupta S, Agrawal A, Agrawal S, et al. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun Ageing 2006; 19: 3-5.
108. High KP. Micronutrient supplementation and immune function in the elderly. Clin Infect Dis 1999; 28(4): 717-722.
109. Smith TP, Kennedy SL, Fleshner M. Influence of age and physical activity on the primary in-vivo antibody and T-cell-mediated response in men. J Appl Physiol 2004; 97(2): 491-498.
110. Sonneborn JS. The myth and reality of reversal of aging by hormesis. Ann N Y Acad Sci 2005; 1057: 165-176.
111. Fulop T, Wagner JR, Khalil A, et al. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol 1999; 54(2): M59-M64.
112. Fulop T Jr, Larbi A, Dupuis G, et al. Ageing, autoimmunity and arthritis: perturbations of TCR signal transduction pathways with ageing-a biochemical paradigm for the ageing immune system. Arthritis Res Ther 2003; 5(6): 290-302.
113. Maletto B, Ropolo A, Moron V. Pistoresi-Palencia MC CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. J Leukoc Biol 2002; 72(3): 447-454.
114. Bansal-Pakala P, Croft M. Defective T-cell priming associated with aging can be rescued by signaling through 4-1BB (CD137). J Immunol 2002; 169(9): 5005-5009.
115. Utsuyama M, Wakikawa A, Tamura T, et al. Impairment of signal transduction in T cells from old mice. Mech Ageing Dev 1997; 93(1-3): 131-144.